MangoRx TRT & Testosterone Review
From $59/mo · Free consult · 3.9★ on Trustpilot · Most States
5 verified reviews
NASDAQ-listed multi-modality TRT including FDA-approved oral Kyzatrex — broader medication catalog than typical mass-market telehealth, smaller track record.
Is MangoRx the right fit for you?
Who it's for
- Men wanting full TRT modality range under one provider — MangoRx offers injectable testosterone cypionate ($99/mo all-inclusive), FDA-approved oral Kyzatrex (testosterone undecanoate), and enclomiphene; almost no other telehealth offers all three including FDA-approved oral testosterone
- Patients curious about Kyzatrex specifically — it's an FDA-approved oral testosterone undecanoate that's rare in telehealth because most providers default to injectable or topical. MangoRx's Kyzatrex availability is a genuine differentiator
- Buyers who value NASDAQ-listed operator credibility (Mangoceuticals, Inc., MGRX) and LegitScript certification — institutional trust signals above typical mass-market telehealth
- Cost-sensitive TRT shoppers — the $99/mo all-inclusive injectable pricing is at the entry-tier with labs INCLUDED, vs PeterMD's $79–$139/mo plus separate $190 labs
Who it's not for
- Men needing layered hormone-and-metabolic optimization beyond TRT itself — MangoRx is TRT-focused; Marek's comprehensive panel (thyroid, adrenal, advanced lipids, inflammatory markers) is the appropriate match for cases requiring broader workup
- Patients who value extensive operating-history track record — MangoRx is publicly traded but newer to the established telehealth landscape; the review base (~5 high-rated reviews per Trustpilot) is much smaller than Hims (7,800+) or PeterMD (13,000+) at this stage
- Anyone in a state MangoRx doesn't serve — coverage is documented as "Most States" rather than all 50; verify your state availability during intake
- Patients who specifically want topical testosterone cream — Fountain TRT specializes in the cream pathway and has deeper protocol expertise on that modality than MangoRx, which positions cream as a non-default option
Your first 3 months with MangoRx
Complete the MangoRx TRT intake — symptom inventory, medical history, current medications, and modality preference (injectable / Kyzatrex oral / enclomiphene). Free physician consult is the platform default; same-day intake processing is typical.
Video consult with a licensed physician. Lab order issued — covers hormone panel appropriate for the modality chosen. For Kyzatrex, the panel checks include baseline hepatic function (Kyzatrex has a different absorption pathway than injectable). Local LabCorp or Quest draw; results in 2–3 business days.
Lab review confirms protocol candidacy. First medication shipment lands — same-day shipping is typical for MangoRx, faster than most TRT competitors. For injectable patients: typical start is testosterone cypionate 100mg weekly or 200mg bi-weekly. For Kyzatrex patients: typical start is 200mg twice daily with meals. For enclomiphene patients: 12.5–25mg every other day. Symptom response timing varies by modality.
Follow-up labs at 8–12 weeks confirm response. For Kyzatrex specifically, the absorption-with-food dependency matters — patients who skip meals during dosing windows can underrespond. Dose titration based on lab response and symptom tracking. Same all-inclusive pricing covers follow-up consults and ongoing labs.
MangoRx vs the alternatives
[PeterMD](/online-providers/trt-testosterone/petermd) and MangoRx compete on multi-modality TRT — both offer injectable, oral (PeterMD enclomiphene, MangoRx enclomiphene + Kyzatrex), and topical cream. MangoRx's edge: Kyzatrex is FDA-approved oral testosterone undecanoate (PeterMD doesn't carry it), and MangoRx's $99/mo all-inclusive bundles labs vs PeterMD's separate $190 baseline-labs charge. PeterMD's edge: larger operating-history track record (13,000+ Trustpilot reviews vs MangoRx's 5+), broader brand recognition, established multi-year operating history. AHF rates PeterMD 4.3 and MangoRx 4.1 (TRT) — gap reflects operating-history depth vs MangoRx's institutional-credibility-with-broader-catalog framing.
[Marek Health](/online-providers/trt-testosterone/marek-health) is the premium-concierge model at $300–$500+/mo all-in with comprehensive panel work (full thyroid, adrenal, advanced lipids, inflammatory markers). MangoRx is mid-tier entry-priced at $99/mo all-inclusive with multi-modality TRT focus. AHF rates Marek 4.4 and MangoRx 4.1 (TRT). Pick Marek if you want comprehensive hormone-and-metabolic context and your case warrants the premium clinical depth. Pick MangoRx if focused TRT with multi-modality (injectable + Kyzatrex + enclomiphene) at the entry tier is the appropriate match — and the NASDAQ-listed institutional credibility appeals.
Honest Breakdown
What Works Well
- Innovative oral dissolving tablets for faster absorption
- Injectable TRT at $99/month all-inclusive with labs
- Publicly traded company (NASDAQ: MGRX)
- Free provider visits and shipping on all orders
- LegitScript certified and HIPAA compliant
- Multiple TRT options: injectable, oral, and enclomiphene
Watch Points
What people actually ask about MangoRx
Yes — MangoRx operates as Mangoceuticals, Inc. (NASDAQ: MGRX), a publicly traded telehealth company with LegitScript certification and HIPAA compliance. The public-company structure adds an institutional-credibility layer above typical mass-market telehealth (SEC filings, board governance, audited financials). Licensed physicians prescribe in covered states, FDA-registered pharmacies dispense medications including FDA-approved Kyzatrex. The watch points: shorter operating-history track record than long-established competitors, and a much smaller review base (~5 Trustpilot reviews vs Hims 7,800+) at current stage.
Ready to start with MangoRx?
Free consultation. Independently reviewed. Board-certified physicians.
Get Free ConsultationSecure telemedicine · HIPAA compliant · Cancel anytime